EDIL3 is a potential prognostic biomarker that correlates with immune infiltrates in gastric cancer
Article in PeerJ (August 2023)
The most recent citing publications are shown below. View all 23 publications that cite this research output on Dimensions.
Article in PeerJ (August 2023)
Article in Canadian Journal of Physiology and Pharmacology (July 2023)
Preprint in Research Square (October 2022)